Agenda

25
Nov.

10h45, Ask the Expert: Targeting the non immune tumor stroma to improve immunotherapy *** 12h15, SecMed Seminar: CCL19⁺ fibroblast niches support PD-1 blockade therapeutic efficacy in triple-negative breast cancer

Spezialisiert / Akademisch Seminar
25.11.2026 10:45 - 13:30
+ Hybridveranstaltung)